nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitrazepam—ABCB1—Mitomycin—urinary bladder cancer	0.163	0.328	CbGbCtD
Nitrazepam—CYP3A4—Thiotepa—urinary bladder cancer	0.0739	0.149	CbGbCtD
Nitrazepam—CYP2E1—Etoposide—urinary bladder cancer	0.0661	0.133	CbGbCtD
Nitrazepam—ABCB1—Gemcitabine—urinary bladder cancer	0.0468	0.0945	CbGbCtD
Nitrazepam—ABCB1—Cisplatin—urinary bladder cancer	0.034	0.0686	CbGbCtD
Nitrazepam—ABCB1—Etoposide—urinary bladder cancer	0.0334	0.0675	CbGbCtD
Nitrazepam—ABCB1—Doxorubicin—urinary bladder cancer	0.0228	0.046	CbGbCtD
Nitrazepam—ABCB1—Methotrexate—urinary bladder cancer	0.0221	0.0446	CbGbCtD
Nitrazepam—CYP3A4—Etoposide—urinary bladder cancer	0.02	0.0404	CbGbCtD
Nitrazepam—CYP3A4—Doxorubicin—urinary bladder cancer	0.0137	0.0276	CbGbCtD
Nitrazepam—Flurbiprofen—UGT2B7—urinary bladder cancer	0.00457	0.272	CrCbGaD
Nitrazepam—Clonazepam—NAT2—urinary bladder cancer	0.00453	0.269	CrCbGaD
Nitrazepam—Flunitrazepam—UGT2B7—urinary bladder cancer	0.00391	0.233	CrCbGaD
Nitrazepam—Oxazepam—UGT2B7—urinary bladder cancer	0.00304	0.181	CrCbGaD
Nitrazepam—CYP2E1—urine—urinary bladder cancer	0.00299	0.0846	CbGeAlD
Nitrazepam—GABRP—prostate gland—urinary bladder cancer	0.0026	0.0738	CbGeAlD
Nitrazepam—CYP3A4—urine—urinary bladder cancer	0.0024	0.0681	CbGeAlD
Nitrazepam—GABRE—prostate gland—urinary bladder cancer	0.00199	0.0563	CbGeAlD
Nitrazepam—GABRP—urethra—urinary bladder cancer	0.00174	0.0494	CbGeAlD
Nitrazepam—GABRB3—prostate gland—urinary bladder cancer	0.00169	0.0477	CbGeAlD
Nitrazepam—GABRE—seminal vesicle—urinary bladder cancer	0.00168	0.0476	CbGeAlD
Nitrazepam—GABRB1—vagina—urinary bladder cancer	0.00144	0.0407	CbGeAlD
Nitrazepam—GABRP—female reproductive system—urinary bladder cancer	0.00142	0.0403	CbGeAlD
Nitrazepam—GABRE—urethra—urinary bladder cancer	0.00133	0.0377	CbGeAlD
Nitrazepam—Dysarthria—Doxorubicin—urinary bladder cancer	0.00129	0.00292	CcSEcCtD
Nitrazepam—Jaundice—Etoposide—urinary bladder cancer	0.00129	0.00291	CcSEcCtD
Nitrazepam—Leukopenia—Thiotepa—urinary bladder cancer	0.00129	0.0029	CcSEcCtD
Nitrazepam—GABRP—vagina—urinary bladder cancer	0.00129	0.0364	CbGeAlD
Nitrazepam—Salivary hypersecretion—Epirubicin—urinary bladder cancer	0.00129	0.0029	CcSEcCtD
Nitrazepam—Gait disturbance—Doxorubicin—urinary bladder cancer	0.00125	0.00283	CcSEcCtD
Nitrazepam—Coordination abnormal—Doxorubicin—urinary bladder cancer	0.00125	0.00282	CcSEcCtD
Nitrazepam—Convulsion—Thiotepa—urinary bladder cancer	0.00125	0.00281	CcSEcCtD
Nitrazepam—Agranulocytosis—Etoposide—urinary bladder cancer	0.00123	0.00278	CcSEcCtD
Nitrazepam—Anxiety—Thiotepa—urinary bladder cancer	0.00122	0.00275	CcSEcCtD
Nitrazepam—Abnormal dreams—Doxorubicin—urinary bladder cancer	0.00121	0.00273	CcSEcCtD
Nitrazepam—Salivary hypersecretion—Doxorubicin—urinary bladder cancer	0.00119	0.00269	CcSEcCtD
Nitrazepam—GABRR2—lymph node—urinary bladder cancer	0.00119	0.0337	CbGeAlD
Nitrazepam—Confusional state—Thiotepa—urinary bladder cancer	0.00118	0.00267	CcSEcCtD
Nitrazepam—Hypoaesthesia—Etoposide—urinary bladder cancer	0.00118	0.00266	CcSEcCtD
Nitrazepam—Infection—Thiotepa—urinary bladder cancer	0.00117	0.00263	CcSEcCtD
Nitrazepam—Mental disability—Epirubicin—urinary bladder cancer	0.00115	0.00259	CcSEcCtD
Nitrazepam—Vision blurred—Fluorouracil—urinary bladder cancer	0.00112	0.00253	CcSEcCtD
Nitrazepam—Malaise—Gemcitabine—urinary bladder cancer	0.00109	0.00246	CcSEcCtD
Nitrazepam—GABRE—female reproductive system—urinary bladder cancer	0.00109	0.0307	CbGeAlD
Nitrazepam—Muscle spasms—Cisplatin—urinary bladder cancer	0.00108	0.00245	CcSEcCtD
Nitrazepam—Leukopenia—Gemcitabine—urinary bladder cancer	0.00108	0.00244	CcSEcCtD
Nitrazepam—CYP2E1—prostate gland—urinary bladder cancer	0.00107	0.0304	CbGeAlD
Nitrazepam—Leukopenia—Fluorouracil—urinary bladder cancer	0.00106	0.0024	CcSEcCtD
Nitrazepam—Mental disability—Doxorubicin—urinary bladder cancer	0.00106	0.0024	CcSEcCtD
Nitrazepam—Vision blurred—Cisplatin—urinary bladder cancer	0.00106	0.0024	CcSEcCtD
Nitrazepam—Tremor—Cisplatin—urinary bladder cancer	0.00106	0.00238	CcSEcCtD
Nitrazepam—Paraesthesia—Thiotepa—urinary bladder cancer	0.00105	0.00238	CcSEcCtD
Nitrazepam—Lethargy—Methotrexate—urinary bladder cancer	0.00105	0.00237	CcSEcCtD
Nitrazepam—Somnolence—Thiotepa—urinary bladder cancer	0.00104	0.00235	CcSEcCtD
Nitrazepam—Dyspepsia—Thiotepa—urinary bladder cancer	0.00103	0.00233	CcSEcCtD
Nitrazepam—Convulsion—Fluorouracil—urinary bladder cancer	0.00103	0.00232	CcSEcCtD
Nitrazepam—Malaise—Cisplatin—urinary bladder cancer	0.00102	0.00229	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.00101	0.00229	CcSEcCtD
Nitrazepam—Fatigue—Thiotepa—urinary bladder cancer	0.00101	0.00228	CcSEcCtD
Nitrazepam—Leukopenia—Cisplatin—urinary bladder cancer	0.00101	0.00228	CcSEcCtD
Nitrazepam—Constipation—Thiotepa—urinary bladder cancer	0.001	0.00226	CcSEcCtD
Nitrazepam—Muscle spasms—Etoposide—urinary bladder cancer	0.000992	0.00224	CcSEcCtD
Nitrazepam—GABRA2—vagina—urinary bladder cancer	0.00099	0.028	CbGeAlD
Nitrazepam—GABRE—vagina—urinary bladder cancer	0.000982	0.0278	CbGeAlD
Nitrazepam—Lethargy—Epirubicin—urinary bladder cancer	0.00098	0.00221	CcSEcCtD
Nitrazepam—Infection—Gemcitabine—urinary bladder cancer	0.00098	0.00221	CcSEcCtD
Nitrazepam—Irritability—Methotrexate—urinary bladder cancer	0.00098	0.00221	CcSEcCtD
Nitrazepam—Confusional state—Fluorouracil—urinary bladder cancer	0.000978	0.00221	CcSEcCtD
Nitrazepam—Convulsion—Cisplatin—urinary bladder cancer	0.000976	0.0022	CcSEcCtD
Nitrazepam—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000966	0.00218	CcSEcCtD
Nitrazepam—Ataxia—Methotrexate—urinary bladder cancer	0.000965	0.00218	CcSEcCtD
Nitrazepam—Infection—Fluorouracil—urinary bladder cancer	0.000964	0.00218	CcSEcCtD
Nitrazepam—Diplopia—Epirubicin—urinary bladder cancer	0.000961	0.00217	CcSEcCtD
Nitrazepam—Anxiety—Cisplatin—urinary bladder cancer	0.000956	0.00216	CcSEcCtD
Nitrazepam—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.000954	0.00215	CcSEcCtD
Nitrazepam—Malaise—Etoposide—urinary bladder cancer	0.000931	0.0021	CcSEcCtD
Nitrazepam—Vertigo—Etoposide—urinary bladder cancer	0.000927	0.00209	CcSEcCtD
Nitrazepam—Leukopenia—Etoposide—urinary bladder cancer	0.000924	0.00209	CcSEcCtD
Nitrazepam—Hypotension—Gemcitabine—urinary bladder cancer	0.000922	0.00208	CcSEcCtD
Nitrazepam—GABRB3—female reproductive system—urinary bladder cancer	0.00092	0.0261	CbGeAlD
Nitrazepam—Infection—Cisplatin—urinary bladder cancer	0.000914	0.00206	CcSEcCtD
Nitrazepam—Loss of consciousness—Etoposide—urinary bladder cancer	0.000907	0.00205	CcSEcCtD
Nitrazepam—Lethargy—Doxorubicin—urinary bladder cancer	0.000907	0.00205	CcSEcCtD
Nitrazepam—CYP2E1—seminal vesicle—urinary bladder cancer	0.000907	0.0257	CbGeAlD
Nitrazepam—Hypotension—Fluorouracil—urinary bladder cancer	0.000906	0.00205	CcSEcCtD
Nitrazepam—Ataxia—Epirubicin—urinary bladder cancer	0.000903	0.00204	CcSEcCtD
Nitrazepam—Convulsion—Etoposide—urinary bladder cancer	0.000894	0.00202	CcSEcCtD
Nitrazepam—Diplopia—Doxorubicin—urinary bladder cancer	0.000889	0.00201	CcSEcCtD
Nitrazepam—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.000889	0.00201	CcSEcCtD
Nitrazepam—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000886	0.002	CcSEcCtD
Nitrazepam—Dyspnoea—Gemcitabine—urinary bladder cancer	0.00088	0.00199	CcSEcCtD
Nitrazepam—Somnolence—Gemcitabine—urinary bladder cancer	0.000877	0.00198	CcSEcCtD
Nitrazepam—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000871	0.00197	CcSEcCtD
Nitrazepam—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000865	0.00195	CcSEcCtD
Nitrazepam—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000864	0.00195	CcSEcCtD
Nitrazepam—Somnolence—Fluorouracil—urinary bladder cancer	0.000862	0.00195	CcSEcCtD
Nitrazepam—Hypotension—Cisplatin—urinary bladder cancer	0.000859	0.00194	CcSEcCtD
Nitrazepam—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000854	0.00193	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000852	0.00192	CcSEcCtD
Nitrazepam—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.000851	0.00192	CcSEcCtD
Nitrazepam—Fatigue—Gemcitabine—urinary bladder cancer	0.000851	0.00192	CcSEcCtD
Nitrazepam—Confusional state—Etoposide—urinary bladder cancer	0.000849	0.00192	CcSEcCtD
Nitrazepam—Muscular weakness—Epirubicin—urinary bladder cancer	0.000847	0.00191	CcSEcCtD
Nitrazepam—Constipation—Gemcitabine—urinary bladder cancer	0.000844	0.0019	CcSEcCtD
Nitrazepam—Asthenia—Thiotepa—urinary bladder cancer	0.000841	0.0019	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000837	0.00189	CcSEcCtD
Nitrazepam—Infection—Etoposide—urinary bladder cancer	0.000837	0.00189	CcSEcCtD
Nitrazepam—Ataxia—Doxorubicin—urinary bladder cancer	0.000836	0.00189	CcSEcCtD
Nitrazepam—Dysphagia—Epirubicin—urinary bladder cancer	0.00083	0.00187	CcSEcCtD
Nitrazepam—Pruritus—Thiotepa—urinary bladder cancer	0.00083	0.00187	CcSEcCtD
Nitrazepam—Paraesthesia—Cisplatin—urinary bladder cancer	0.000826	0.00186	CcSEcCtD
Nitrazepam—Dyspnoea—Cisplatin—urinary bladder cancer	0.00082	0.00185	CcSEcCtD
Nitrazepam—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000814	0.00184	CcSEcCtD
Nitrazepam—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000813	0.00184	CcSEcCtD
Nitrazepam—Diarrhoea—Thiotepa—urinary bladder cancer	0.000802	0.00181	CcSEcCtD
Nitrazepam—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000799	0.0018	CcSEcCtD
Nitrazepam—Pneumonia—Methotrexate—urinary bladder cancer	0.000796	0.0018	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000794	0.00179	CcSEcCtD
Nitrazepam—Drowsiness—Methotrexate—urinary bladder cancer	0.000791	0.00179	CcSEcCtD
Nitrazepam—Hypotension—Etoposide—urinary bladder cancer	0.000787	0.00178	CcSEcCtD
Nitrazepam—Muscular weakness—Doxorubicin—urinary bladder cancer	0.000784	0.00177	CcSEcCtD
Nitrazepam—Dizziness—Thiotepa—urinary bladder cancer	0.000776	0.00175	CcSEcCtD
Nitrazepam—Dysphagia—Doxorubicin—urinary bladder cancer	0.000768	0.00173	CcSEcCtD
Nitrazepam—Sweating—Methotrexate—urinary bladder cancer	0.000759	0.00171	CcSEcCtD
Nitrazepam—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000758	0.00171	CcSEcCtD
Nitrazepam—Paraesthesia—Etoposide—urinary bladder cancer	0.000756	0.00171	CcSEcCtD
Nitrazepam—Flurbiprofen—PTGS2—urinary bladder cancer	0.000754	0.0448	CrCbGaD
Nitrazepam—Dyspnoea—Etoposide—urinary bladder cancer	0.000751	0.0017	CcSEcCtD
Nitrazepam—Somnolence—Etoposide—urinary bladder cancer	0.000749	0.00169	CcSEcCtD
Nitrazepam—Vomiting—Thiotepa—urinary bladder cancer	0.000746	0.00168	CcSEcCtD
Nitrazepam—Pneumonia—Epirubicin—urinary bladder cancer	0.000745	0.00168	CcSEcCtD
Nitrazepam—Drowsiness—Epirubicin—urinary bladder cancer	0.00074	0.00167	CcSEcCtD
Nitrazepam—Rash—Thiotepa—urinary bladder cancer	0.000739	0.00167	CcSEcCtD
Nitrazepam—Dermatitis—Thiotepa—urinary bladder cancer	0.000739	0.00167	CcSEcCtD
Nitrazepam—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000738	0.00167	CcSEcCtD
Nitrazepam—Headache—Thiotepa—urinary bladder cancer	0.000735	0.00166	CcSEcCtD
Nitrazepam—CYP2E1—renal system—urinary bladder cancer	0.000731	0.0207	CbGeAlD
Nitrazepam—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000727	0.00164	CcSEcCtD
Nitrazepam—Fatigue—Etoposide—urinary bladder cancer	0.000726	0.00164	CcSEcCtD
Nitrazepam—Jaundice—Epirubicin—urinary bladder cancer	0.000722	0.00163	CcSEcCtD
Nitrazepam—Constipation—Etoposide—urinary bladder cancer	0.00072	0.00163	CcSEcCtD
Nitrazepam—CYP2E1—urethra—urinary bladder cancer	0.000718	0.0203	CbGeAlD
Nitrazepam—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000715	0.00161	CcSEcCtD
Nitrazepam—Sweating—Epirubicin—urinary bladder cancer	0.00071	0.0016	CcSEcCtD
Nitrazepam—Asthenia—Gemcitabine—urinary bladder cancer	0.000708	0.0016	CcSEcCtD
Nitrazepam—Pruritus—Gemcitabine—urinary bladder cancer	0.000698	0.00158	CcSEcCtD
Nitrazepam—Nausea—Thiotepa—urinary bladder cancer	0.000697	0.00157	CcSEcCtD
Nitrazepam—Feeling abnormal—Etoposide—urinary bladder cancer	0.000694	0.00157	CcSEcCtD
Nitrazepam—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000691	0.00156	CcSEcCtD
Nitrazepam—Pneumonia—Doxorubicin—urinary bladder cancer	0.000689	0.00156	CcSEcCtD
Nitrazepam—Pruritus—Fluorouracil—urinary bladder cancer	0.000686	0.00155	CcSEcCtD
Nitrazepam—Drowsiness—Doxorubicin—urinary bladder cancer	0.000685	0.00155	CcSEcCtD
Nitrazepam—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000678	0.00153	CcSEcCtD
Nitrazepam—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000675	0.00152	CcSEcCtD
Nitrazepam—Jaundice—Doxorubicin—urinary bladder cancer	0.000668	0.00151	CcSEcCtD
Nitrazepam—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000664	0.0015	CcSEcCtD
Nitrazepam—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000661	0.00149	CcSEcCtD
Nitrazepam—Asthenia—Cisplatin—urinary bladder cancer	0.00066	0.00149	CcSEcCtD
Nitrazepam—Sweating—Doxorubicin—urinary bladder cancer	0.000657	0.00148	CcSEcCtD
Nitrazepam—Dizziness—Fluorouracil—urinary bladder cancer	0.000641	0.00145	CcSEcCtD
Nitrazepam—GABRA2—lymph node—urinary bladder cancer	0.00064	0.0181	CbGeAlD
Nitrazepam—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000639	0.00144	CcSEcCtD
Nitrazepam—GABRE—lymph node—urinary bladder cancer	0.000635	0.018	CbGeAlD
Nitrazepam—Diarrhoea—Cisplatin—urinary bladder cancer	0.000629	0.00142	CcSEcCtD
Nitrazepam—Vomiting—Gemcitabine—urinary bladder cancer	0.000627	0.00142	CcSEcCtD
Nitrazepam—Rash—Gemcitabine—urinary bladder cancer	0.000622	0.0014	CcSEcCtD
Nitrazepam—Dermatitis—Gemcitabine—urinary bladder cancer	0.000621	0.0014	CcSEcCtD
Nitrazepam—Hypersensitivity—Etoposide—urinary bladder cancer	0.000621	0.0014	CcSEcCtD
Nitrazepam—Headache—Gemcitabine—urinary bladder cancer	0.000618	0.0014	CcSEcCtD
Nitrazepam—Vomiting—Fluorouracil—urinary bladder cancer	0.000617	0.00139	CcSEcCtD
Nitrazepam—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000612	0.00138	CcSEcCtD
Nitrazepam—Rash—Fluorouracil—urinary bladder cancer	0.000612	0.00138	CcSEcCtD
Nitrazepam—Dermatitis—Fluorouracil—urinary bladder cancer	0.000611	0.00138	CcSEcCtD
Nitrazepam—ABCB1—prostate gland—urinary bladder cancer	0.000611	0.0173	CbGeAlD
Nitrazepam—Headache—Fluorouracil—urinary bladder cancer	0.000608	0.00137	CcSEcCtD
Nitrazepam—Asthenia—Etoposide—urinary bladder cancer	0.000604	0.00136	CcSEcCtD
Nitrazepam—Pruritus—Etoposide—urinary bladder cancer	0.000596	0.00135	CcSEcCtD
Nitrazepam—CYP3A4—renal system—urinary bladder cancer	0.000588	0.0167	CbGeAlD
Nitrazepam—Nausea—Gemcitabine—urinary bladder cancer	0.000586	0.00132	CcSEcCtD
Nitrazepam—CYP2E1—female reproductive system—urinary bladder cancer	0.000585	0.0166	CbGeAlD
Nitrazepam—Vomiting—Cisplatin—urinary bladder cancer	0.000585	0.00132	CcSEcCtD
Nitrazepam—Vision blurred—Methotrexate—urinary bladder cancer	0.000583	0.00132	CcSEcCtD
Nitrazepam—Rash—Cisplatin—urinary bladder cancer	0.00058	0.00131	CcSEcCtD
Nitrazepam—Dermatitis—Cisplatin—urinary bladder cancer	0.000579	0.00131	CcSEcCtD
Nitrazepam—Diarrhoea—Etoposide—urinary bladder cancer	0.000576	0.0013	CcSEcCtD
Nitrazepam—Nausea—Fluorouracil—urinary bladder cancer	0.000576	0.0013	CcSEcCtD
Nitrazepam—Tension—Epirubicin—urinary bladder cancer	0.000568	0.00128	CcSEcCtD
Nitrazepam—Nervousness—Epirubicin—urinary bladder cancer	0.000562	0.00127	CcSEcCtD
Nitrazepam—Malaise—Methotrexate—urinary bladder cancer	0.000558	0.00126	CcSEcCtD
Nitrazepam—Dizziness—Etoposide—urinary bladder cancer	0.000557	0.00126	CcSEcCtD
Nitrazepam—Muscle spasms—Epirubicin—urinary bladder cancer	0.000556	0.00126	CcSEcCtD
Nitrazepam—Vertigo—Methotrexate—urinary bladder cancer	0.000556	0.00125	CcSEcCtD
Nitrazepam—Leukopenia—Methotrexate—urinary bladder cancer	0.000553	0.00125	CcSEcCtD
Nitrazepam—Nausea—Cisplatin—urinary bladder cancer	0.000546	0.00123	CcSEcCtD
Nitrazepam—Vision blurred—Epirubicin—urinary bladder cancer	0.000545	0.00123	CcSEcCtD
Nitrazepam—Convulsion—Methotrexate—urinary bladder cancer	0.000536	0.00121	CcSEcCtD
Nitrazepam—Vomiting—Etoposide—urinary bladder cancer	0.000536	0.00121	CcSEcCtD
Nitrazepam—Agitation—Epirubicin—urinary bladder cancer	0.000532	0.0012	CcSEcCtD
Nitrazepam—Rash—Etoposide—urinary bladder cancer	0.000531	0.0012	CcSEcCtD
Nitrazepam—Dermatitis—Etoposide—urinary bladder cancer	0.000531	0.0012	CcSEcCtD
Nitrazepam—Headache—Etoposide—urinary bladder cancer	0.000528	0.00119	CcSEcCtD
Nitrazepam—Tension—Doxorubicin—urinary bladder cancer	0.000525	0.00119	CcSEcCtD
Nitrazepam—Malaise—Epirubicin—urinary bladder cancer	0.000522	0.00118	CcSEcCtD
Nitrazepam—Nervousness—Doxorubicin—urinary bladder cancer	0.00052	0.00117	CcSEcCtD
Nitrazepam—Vertigo—Epirubicin—urinary bladder cancer	0.00052	0.00117	CcSEcCtD
Nitrazepam—Syncope—Epirubicin—urinary bladder cancer	0.000519	0.00117	CcSEcCtD
Nitrazepam—Leukopenia—Epirubicin—urinary bladder cancer	0.000518	0.00117	CcSEcCtD
Nitrazepam—ABCB1—seminal vesicle—urinary bladder cancer	0.000517	0.0146	CbGeAlD
Nitrazepam—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000515	0.00116	CcSEcCtD
Nitrazepam—Palpitations—Epirubicin—urinary bladder cancer	0.000511	0.00115	CcSEcCtD
Nitrazepam—Confusional state—Methotrexate—urinary bladder cancer	0.000509	0.00115	CcSEcCtD
Nitrazepam—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000509	0.00115	CcSEcCtD
Nitrazepam—Vision blurred—Doxorubicin—urinary bladder cancer	0.000505	0.00114	CcSEcCtD
Nitrazepam—Convulsion—Epirubicin—urinary bladder cancer	0.000501	0.00113	CcSEcCtD
Nitrazepam—Infection—Methotrexate—urinary bladder cancer	0.000501	0.00113	CcSEcCtD
Nitrazepam—Nausea—Etoposide—urinary bladder cancer	0.0005	0.00113	CcSEcCtD
Nitrazepam—Agitation—Doxorubicin—urinary bladder cancer	0.000492	0.00111	CcSEcCtD
Nitrazepam—Anxiety—Epirubicin—urinary bladder cancer	0.000491	0.00111	CcSEcCtD
Nitrazepam—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000488	0.0011	CcSEcCtD
Nitrazepam—Malaise—Doxorubicin—urinary bladder cancer	0.000483	0.00109	CcSEcCtD
Nitrazepam—Vertigo—Doxorubicin—urinary bladder cancer	0.000481	0.00109	CcSEcCtD
Nitrazepam—Syncope—Doxorubicin—urinary bladder cancer	0.00048	0.00108	CcSEcCtD
Nitrazepam—Leukopenia—Doxorubicin—urinary bladder cancer	0.000479	0.00108	CcSEcCtD
Nitrazepam—Confusional state—Epirubicin—urinary bladder cancer	0.000476	0.00108	CcSEcCtD
Nitrazepam—Palpitations—Doxorubicin—urinary bladder cancer	0.000473	0.00107	CcSEcCtD
Nitrazepam—Hypotension—Methotrexate—urinary bladder cancer	0.000472	0.00106	CcSEcCtD
Nitrazepam—CYP3A4—female reproductive system—urinary bladder cancer	0.000471	0.0133	CbGeAlD
Nitrazepam—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000471	0.00106	CcSEcCtD
Nitrazepam—Infection—Epirubicin—urinary bladder cancer	0.000469	0.00106	CcSEcCtD
Nitrazepam—Shock—Epirubicin—urinary bladder cancer	0.000465	0.00105	CcSEcCtD
Nitrazepam—Convulsion—Doxorubicin—urinary bladder cancer	0.000464	0.00105	CcSEcCtD
Nitrazepam—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000457	0.00103	CcSEcCtD
Nitrazepam—Anxiety—Doxorubicin—urinary bladder cancer	0.000454	0.00103	CcSEcCtD
Nitrazepam—Paraesthesia—Methotrexate—urinary bladder cancer	0.000453	0.00102	CcSEcCtD
Nitrazepam—Dyspnoea—Methotrexate—urinary bladder cancer	0.00045	0.00102	CcSEcCtD
Nitrazepam—ABCB1—epithelium—urinary bladder cancer	0.000449	0.0127	CbGeAlD
Nitrazepam—Somnolence—Methotrexate—urinary bladder cancer	0.000449	0.00101	CcSEcCtD
Nitrazepam—Dyspepsia—Methotrexate—urinary bladder cancer	0.000444	0.001	CcSEcCtD
Nitrazepam—Hypotension—Epirubicin—urinary bladder cancer	0.000441	0.000996	CcSEcCtD
Nitrazepam—Confusional state—Doxorubicin—urinary bladder cancer	0.000441	0.000995	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000436	0.000984	CcSEcCtD
Nitrazepam—Fatigue—Methotrexate—urinary bladder cancer	0.000435	0.000982	CcSEcCtD
Nitrazepam—Infection—Doxorubicin—urinary bladder cancer	0.000434	0.00098	CcSEcCtD
Nitrazepam—Shock—Doxorubicin—urinary bladder cancer	0.00043	0.000971	CcSEcCtD
Nitrazepam—Paraesthesia—Epirubicin—urinary bladder cancer	0.000424	0.000957	CcSEcCtD
Nitrazepam—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000422	0.000954	CcSEcCtD
Nitrazepam—Dyspnoea—Epirubicin—urinary bladder cancer	0.000421	0.000951	CcSEcCtD
Nitrazepam—Somnolence—Epirubicin—urinary bladder cancer	0.00042	0.000948	CcSEcCtD
Nitrazepam—ABCB1—renal system—urinary bladder cancer	0.000416	0.0118	CbGeAlD
Nitrazepam—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000416	0.000939	CcSEcCtD
Nitrazepam—Dyspepsia—Epirubicin—urinary bladder cancer	0.000416	0.000939	CcSEcCtD
Nitrazepam—ABCB1—urethra—urinary bladder cancer	0.000409	0.0116	CbGeAlD
Nitrazepam—Hypotension—Doxorubicin—urinary bladder cancer	0.000408	0.000922	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000408	0.00092	CcSEcCtD
Nitrazepam—Fatigue—Epirubicin—urinary bladder cancer	0.000407	0.000919	CcSEcCtD
Nitrazepam—Constipation—Epirubicin—urinary bladder cancer	0.000404	0.000912	CcSEcCtD
Nitrazepam—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000392	0.000886	CcSEcCtD
Nitrazepam—Dyspnoea—Doxorubicin—urinary bladder cancer	0.00039	0.00088	CcSEcCtD
Nitrazepam—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000389	0.000879	CcSEcCtD
Nitrazepam—Somnolence—Doxorubicin—urinary bladder cancer	0.000388	0.000877	CcSEcCtD
Nitrazepam—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000385	0.000868	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000377	0.000852	CcSEcCtD
Nitrazepam—Fatigue—Doxorubicin—urinary bladder cancer	0.000377	0.000851	CcSEcCtD
Nitrazepam—Constipation—Doxorubicin—urinary bladder cancer	0.000374	0.000844	CcSEcCtD
Nitrazepam—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000372	0.000839	CcSEcCtD
Nitrazepam—Asthenia—Methotrexate—urinary bladder cancer	0.000362	0.000817	CcSEcCtD
Nitrazepam—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.00036	0.000813	CcSEcCtD
Nitrazepam—Pruritus—Methotrexate—urinary bladder cancer	0.000357	0.000806	CcSEcCtD
Nitrazepam—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000348	0.000786	CcSEcCtD
Nitrazepam—Diarrhoea—Methotrexate—urinary bladder cancer	0.000345	0.00078	CcSEcCtD
Nitrazepam—Asthenia—Epirubicin—urinary bladder cancer	0.000339	0.000765	CcSEcCtD
Nitrazepam—Pruritus—Epirubicin—urinary bladder cancer	0.000334	0.000754	CcSEcCtD
Nitrazepam—Dizziness—Methotrexate—urinary bladder cancer	0.000334	0.000753	CcSEcCtD
Nitrazepam—ABCB1—female reproductive system—urinary bladder cancer	0.000333	0.00944	CbGeAlD
Nitrazepam—Diarrhoea—Epirubicin—urinary bladder cancer	0.000323	0.000729	CcSEcCtD
Nitrazepam—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000322	0.000727	CcSEcCtD
Nitrazepam—Vomiting—Methotrexate—urinary bladder cancer	0.000321	0.000724	CcSEcCtD
Nitrazepam—Rash—Methotrexate—urinary bladder cancer	0.000318	0.000718	CcSEcCtD
Nitrazepam—Dermatitis—Methotrexate—urinary bladder cancer	0.000318	0.000718	CcSEcCtD
Nitrazepam—Headache—Methotrexate—urinary bladder cancer	0.000316	0.000714	CcSEcCtD
Nitrazepam—Asthenia—Doxorubicin—urinary bladder cancer	0.000313	0.000708	CcSEcCtD
Nitrazepam—Dizziness—Epirubicin—urinary bladder cancer	0.000312	0.000705	CcSEcCtD
Nitrazepam—Pruritus—Doxorubicin—urinary bladder cancer	0.000309	0.000698	CcSEcCtD
Nitrazepam—ABCB1—vagina—urinary bladder cancer	0.000301	0.00854	CbGeAlD
Nitrazepam—Vomiting—Epirubicin—urinary bladder cancer	0.0003	0.000678	CcSEcCtD
Nitrazepam—Nausea—Methotrexate—urinary bladder cancer	0.0003	0.000677	CcSEcCtD
Nitrazepam—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000299	0.000675	CcSEcCtD
Nitrazepam—Rash—Epirubicin—urinary bladder cancer	0.000298	0.000672	CcSEcCtD
Nitrazepam—Dermatitis—Epirubicin—urinary bladder cancer	0.000297	0.000672	CcSEcCtD
Nitrazepam—Headache—Epirubicin—urinary bladder cancer	0.000296	0.000668	CcSEcCtD
Nitrazepam—Dizziness—Doxorubicin—urinary bladder cancer	0.000289	0.000652	CcSEcCtD
Nitrazepam—Nausea—Epirubicin—urinary bladder cancer	0.00028	0.000633	CcSEcCtD
Nitrazepam—Vomiting—Doxorubicin—urinary bladder cancer	0.000278	0.000627	CcSEcCtD
Nitrazepam—Rash—Doxorubicin—urinary bladder cancer	0.000276	0.000622	CcSEcCtD
Nitrazepam—Dermatitis—Doxorubicin—urinary bladder cancer	0.000275	0.000621	CcSEcCtD
Nitrazepam—Headache—Doxorubicin—urinary bladder cancer	0.000274	0.000618	CcSEcCtD
Nitrazepam—Nausea—Doxorubicin—urinary bladder cancer	0.00026	0.000586	CcSEcCtD
Nitrazepam—ABCB1—lymph node—urinary bladder cancer	0.000195	0.00552	CbGeAlD
Nitrazepam—GABRG2—Orphan transporters—CREBBP—urinary bladder cancer	2.76e-05	0.00301	CbGpPWpGaD
Nitrazepam—GABRA3—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	2.73e-05	0.00297	CbGpPWpGaD
Nitrazepam—GABRB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	2.73e-05	0.00297	CbGpPWpGaD
Nitrazepam—GABRA2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	2.68e-05	0.00292	CbGpPWpGaD
Nitrazepam—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	2.68e-05	0.00292	CbGpPWpGaD
Nitrazepam—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	2.68e-05	0.00292	CbGpPWpGaD
Nitrazepam—GABRB3—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	2.66e-05	0.0029	CbGpPWpGaD
Nitrazepam—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	2.64e-05	0.00288	CbGpPWpGaD
Nitrazepam—GABRG2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	2.62e-05	0.00285	CbGpPWpGaD
Nitrazepam—GABRA6—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	2.58e-05	0.00281	CbGpPWpGaD
Nitrazepam—GABRA4—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	2.55e-05	0.00278	CbGpPWpGaD
Nitrazepam—CYP2E1—Biological oxidations—HPGDS—urinary bladder cancer	2.53e-05	0.00276	CbGpPWpGaD
Nitrazepam—CYP2E1—Biological oxidations—GSTT1—urinary bladder cancer	2.45e-05	0.00267	CbGpPWpGaD
Nitrazepam—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	2.45e-05	0.00267	CbGpPWpGaD
Nitrazepam—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	2.41e-05	0.00263	CbGpPWpGaD
Nitrazepam—GABRA1—Orphan transporters—CREBBP—urinary bladder cancer	2.41e-05	0.00263	CbGpPWpGaD
Nitrazepam—GABRR1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	2.38e-05	0.0026	CbGpPWpGaD
Nitrazepam—GABRB2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	2.33e-05	0.00254	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	2.29e-05	0.0025	CbGpPWpGaD
Nitrazepam—GABRA1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	2.29e-05	0.00249	CbGpPWpGaD
Nitrazepam—GABRQ—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	2.27e-05	0.00248	CbGpPWpGaD
Nitrazepam—GABRR2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	2.27e-05	0.00248	CbGpPWpGaD
Nitrazepam—GABRA5—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	2.27e-05	0.00247	CbGpPWpGaD
Nitrazepam—ABCB1—HIF-1-alpha transcription factor network—TERT—urinary bladder cancer	2.23e-05	0.00243	CbGpPWpGaD
Nitrazepam—GABRA3—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	2.22e-05	0.00243	CbGpPWpGaD
Nitrazepam—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	2.2e-05	0.0024	CbGpPWpGaD
Nitrazepam—GABRA2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	2.19e-05	0.00238	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—NCOR1—urinary bladder cancer	2.18e-05	0.00237	CbGpPWpGaD
Nitrazepam—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	2.17e-05	0.00237	CbGpPWpGaD
Nitrazepam—GABRB3—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	2.17e-05	0.00237	CbGpPWpGaD
Nitrazepam—GABRG2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	2.13e-05	0.00232	CbGpPWpGaD
Nitrazepam—ABCB1—Allograft Rejection—FAS—urinary bladder cancer	1.96e-05	0.00214	CbGpPWpGaD
Nitrazepam—SCN1A—Axon guidance—RHOA—urinary bladder cancer	1.9e-05	0.00207	CbGpPWpGaD
Nitrazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	1.9e-05	0.00207	CbGpPWpGaD
Nitrazepam—GABRG3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	1.87e-05	0.00204	CbGpPWpGaD
Nitrazepam—GABRA1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	1.86e-05	0.00203	CbGpPWpGaD
Nitrazepam—GABRB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	1.84e-05	0.00201	CbGpPWpGaD
Nitrazepam—SCN1A—Axon guidance—ERBB2—urinary bladder cancer	1.76e-05	0.00192	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	1.75e-05	0.00191	CbGpPWpGaD
Nitrazepam—GABRA1—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	1.74e-05	0.0019	CbGpPWpGaD
Nitrazepam—GABRA6—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	1.74e-05	0.0019	CbGpPWpGaD
Nitrazepam—ABCB1—HIF-1-alpha transcription factor network—CREBBP—urinary bladder cancer	1.74e-05	0.0019	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	1.74e-05	0.0019	CbGpPWpGaD
Nitrazepam—GABRA4—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	1.72e-05	0.00188	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—CDK4—urinary bladder cancer	1.72e-05	0.00187	CbGpPWpGaD
Nitrazepam—CYP2E1—Biological oxidations—GSTP1—urinary bladder cancer	1.7e-05	0.00185	CbGpPWpGaD
Nitrazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	1.68e-05	0.00183	CbGpPWpGaD
Nitrazepam—CYP2E1—Metapathway biotransformation—GSTP1—urinary bladder cancer	1.68e-05	0.00183	CbGpPWpGaD
Nitrazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	1.6e-05	0.00174	CbGpPWpGaD
Nitrazepam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	1.6e-05	0.00174	CbGpPWpGaD
Nitrazepam—ABCB1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	1.59e-05	0.00173	CbGpPWpGaD
Nitrazepam—GABRB2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	1.58e-05	0.00172	CbGpPWpGaD
Nitrazepam—CYP2E1—Biological oxidations—GSTM1—urinary bladder cancer	1.56e-05	0.0017	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—PPARG—urinary bladder cancer	1.56e-05	0.0017	CbGpPWpGaD
Nitrazepam—CYP2E1—Metapathway biotransformation—GSTM1—urinary bladder cancer	1.54e-05	0.00168	CbGpPWpGaD
Nitrazepam—GABRA5—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	1.53e-05	0.00167	CbGpPWpGaD
Nitrazepam—SCN1A—Axon guidance—MMP9—urinary bladder cancer	1.51e-05	0.00164	CbGpPWpGaD
Nitrazepam—GABRA3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	1.5e-05	0.00164	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—CREBBP—urinary bladder cancer	1.5e-05	0.00163	CbGpPWpGaD
Nitrazepam—GABRA2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	1.48e-05	0.00161	CbGpPWpGaD
Nitrazepam—GABRB3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	1.47e-05	0.0016	CbGpPWpGaD
Nitrazepam—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	1.47e-05	0.0016	CbGpPWpGaD
Nitrazepam—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	1.45e-05	0.00158	CbGpPWpGaD
Nitrazepam—GABRG2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	1.44e-05	0.00157	CbGpPWpGaD
Nitrazepam—GABRB3—BDNF signaling pathway—SRC—urinary bladder cancer	1.44e-05	0.00156	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	1.4e-05	0.00153	CbGpPWpGaD
Nitrazepam—SCN1A—Axon guidance—SRC—urinary bladder cancer	1.39e-05	0.00152	CbGpPWpGaD
Nitrazepam—GABRA1—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	1.39e-05	0.00151	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—RHOA—urinary bladder cancer	1.36e-05	0.00148	CbGpPWpGaD
Nitrazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	1.32e-05	0.00144	CbGpPWpGaD
Nitrazepam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	1.31e-05	0.00143	CbGpPWpGaD
Nitrazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	1.3e-05	0.00142	CbGpPWpGaD
Nitrazepam—GABRR1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	1.26e-05	0.00137	CbGpPWpGaD
Nitrazepam—GABRA1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	1.26e-05	0.00137	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—ERBB2—urinary bladder cancer	1.25e-05	0.00137	CbGpPWpGaD
Nitrazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	1.23e-05	0.00134	CbGpPWpGaD
Nitrazepam—SCN1A—Axon guidance—EGFR—urinary bladder cancer	1.22e-05	0.00133	CbGpPWpGaD
Nitrazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	1.21e-05	0.00132	CbGpPWpGaD
Nitrazepam—GABRR2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	1.2e-05	0.00131	CbGpPWpGaD
Nitrazepam—GABRQ—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	1.2e-05	0.00131	CbGpPWpGaD
Nitrazepam—ABCB1—Allograft Rejection—CXCL8—urinary bladder cancer	1.2e-05	0.00131	CbGpPWpGaD
Nitrazepam—GABRA1—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	1.19e-05	0.0013	CbGpPWpGaD
Nitrazepam—ABCB1—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	1.19e-05	0.00129	CbGpPWpGaD
Nitrazepam—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	1.17e-05	0.00128	CbGpPWpGaD
Nitrazepam—SCN1A—Axon guidance—KRAS—urinary bladder cancer	1.15e-05	0.00125	CbGpPWpGaD
Nitrazepam—ABCB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	1.15e-05	0.00125	CbGpPWpGaD
Nitrazepam—ABCB1—Allograft Rejection—IL2—urinary bladder cancer	1.14e-05	0.00125	CbGpPWpGaD
Nitrazepam—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	1.14e-05	0.00124	CbGpPWpGaD
Nitrazepam—GABRR1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.11e-05	0.00122	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	1.11e-05	0.00121	CbGpPWpGaD
Nitrazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	1.11e-05	0.00121	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	1.09e-05	0.00119	CbGpPWpGaD
Nitrazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	1.08e-05	0.00117	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—MMP9—urinary bladder cancer	1.08e-05	0.00117	CbGpPWpGaD
Nitrazepam—GABRQ—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.06e-05	0.00116	CbGpPWpGaD
Nitrazepam—GABRR2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.06e-05	0.00116	CbGpPWpGaD
Nitrazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	1.06e-05	0.00115	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—GSTZ1—urinary bladder cancer	1.04e-05	0.00113	CbGpPWpGaD
Nitrazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	1.04e-05	0.00113	CbGpPWpGaD
Nitrazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	1.03e-05	0.00113	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—EP300—urinary bladder cancer	1.02e-05	0.00111	CbGpPWpGaD
Nitrazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	1.01e-05	0.00111	CbGpPWpGaD
Nitrazepam—GABRB3—BDNF signaling pathway—HRAS—urinary bladder cancer	1.01e-05	0.0011	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—SRC—urinary bladder cancer	9.92e-06	0.00108	CbGpPWpGaD
Nitrazepam—GABRG3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	9.91e-06	0.00108	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—GSTO2—urinary bladder cancer	9.87e-06	0.00108	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—NAT1—urinary bladder cancer	9.87e-06	0.00108	CbGpPWpGaD
Nitrazepam—SCN1A—Axon guidance—HRAS—urinary bladder cancer	9.78e-06	0.00107	CbGpPWpGaD
Nitrazepam—GABRB1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	9.76e-06	0.00106	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	9.69e-06	0.00106	CbGpPWpGaD
Nitrazepam—GABRR1—Neuronal System—HRAS—urinary bladder cancer	9.66e-06	0.00105	CbGpPWpGaD
Nitrazepam—GABRA1—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	9.65e-06	0.00105	CbGpPWpGaD
Nitrazepam—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	9.35e-06	0.00102	CbGpPWpGaD
Nitrazepam—GABRA6—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	9.24e-06	0.00101	CbGpPWpGaD
Nitrazepam—GABRR2—Neuronal System—HRAS—urinary bladder cancer	9.22e-06	0.00101	CbGpPWpGaD
Nitrazepam—GABRQ—Neuronal System—HRAS—urinary bladder cancer	9.22e-06	0.00101	CbGpPWpGaD
Nitrazepam—GABRA4—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	9.12e-06	0.000994	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—UGT2B7—urinary bladder cancer	9.02e-06	0.000984	CbGpPWpGaD
Nitrazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	8.87e-06	0.000967	CbGpPWpGaD
Nitrazepam—GABRG3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	8.76e-06	0.000955	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—EGFR—urinary bladder cancer	8.7e-06	0.000948	CbGpPWpGaD
Nitrazepam—GABRB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	8.63e-06	0.00094	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	8.56e-06	0.000934	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	8.53e-06	0.00093	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	8.49e-06	0.000926	CbGpPWpGaD
Nitrazepam—GABRB2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	8.34e-06	0.000909	CbGpPWpGaD
Nitrazepam—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	8.34e-06	0.000909	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—TNF—urinary bladder cancer	8.28e-06	0.000903	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—KRAS—urinary bladder cancer	8.21e-06	0.000896	CbGpPWpGaD
Nitrazepam—GABRA6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	8.16e-06	0.00089	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—CYP4B1—urinary bladder cancer	8.13e-06	0.000886	CbGpPWpGaD
Nitrazepam—GABRA5—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	8.1e-06	0.000883	CbGpPWpGaD
Nitrazepam—GABRA4—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	8.06e-06	0.000879	CbGpPWpGaD
Nitrazepam—GABRA3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	7.96e-06	0.000867	CbGpPWpGaD
Nitrazepam—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	7.88e-06	0.000859	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	7.84e-06	0.000854	CbGpPWpGaD
Nitrazepam—GABRA2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	7.82e-06	0.000852	CbGpPWpGaD
Nitrazepam—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	7.77e-06	0.000848	CbGpPWpGaD
Nitrazepam—GABRB3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	7.77e-06	0.000847	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—SLC19A1—urinary bladder cancer	7.67e-06	0.000837	CbGpPWpGaD
Nitrazepam—GABRG2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	7.63e-06	0.000832	CbGpPWpGaD
Nitrazepam—GABRG3—Neuronal System—HRAS—urinary bladder cancer	7.59e-06	0.000828	CbGpPWpGaD
Nitrazepam—GABRB1—Neuronal System—HRAS—urinary bladder cancer	7.48e-06	0.000815	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—PRSS3—urinary bladder cancer	7.48e-06	0.000815	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	7.44e-06	0.000811	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—GSTO2—urinary bladder cancer	7.43e-06	0.00081	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—NAT1—urinary bladder cancer	7.43e-06	0.00081	CbGpPWpGaD
Nitrazepam—GABRB2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	7.37e-06	0.000804	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	7.35e-06	0.000801	CbGpPWpGaD
Nitrazepam—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	7.24e-06	0.00079	CbGpPWpGaD
Nitrazepam—GABRA5—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	7.16e-06	0.000781	CbGpPWpGaD
Nitrazepam—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	7.14e-06	0.000779	CbGpPWpGaD
Nitrazepam—GABRA6—Neuronal System—HRAS—urinary bladder cancer	7.08e-06	0.000771	CbGpPWpGaD
Nitrazepam—GABRA3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	7.03e-06	0.000767	CbGpPWpGaD
Nitrazepam—GABRA4—Neuronal System—HRAS—urinary bladder cancer	6.99e-06	0.000762	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—HRAS—urinary bladder cancer	6.98e-06	0.000761	CbGpPWpGaD
Nitrazepam—GABRA2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.91e-06	0.000753	CbGpPWpGaD
Nitrazepam—GABRB3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.87e-06	0.000748	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	6.8e-06	0.000741	CbGpPWpGaD
Nitrazepam—GABRG2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.74e-06	0.000735	CbGpPWpGaD
Nitrazepam—GABRA1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	6.67e-06	0.000727	CbGpPWpGaD
Nitrazepam—GABRB2—Neuronal System—HRAS—urinary bladder cancer	6.39e-06	0.000697	CbGpPWpGaD
Nitrazepam—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	6.32e-06	0.000689	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	6.23e-06	0.00068	CbGpPWpGaD
Nitrazepam—GABRA5—Neuronal System—HRAS—urinary bladder cancer	6.21e-06	0.000677	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	6.12e-06	0.000667	CbGpPWpGaD
Nitrazepam—GABRA3—Neuronal System—HRAS—urinary bladder cancer	6.1e-06	0.000665	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	6.1e-06	0.000665	CbGpPWpGaD
Nitrazepam—GABRA2—Neuronal System—HRAS—urinary bladder cancer	5.99e-06	0.000653	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—TYMP—urinary bladder cancer	5.98e-06	0.000652	CbGpPWpGaD
Nitrazepam—GABRB3—Neuronal System—HRAS—urinary bladder cancer	5.95e-06	0.000649	CbGpPWpGaD
Nitrazepam—GABRA1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.89e-06	0.000642	CbGpPWpGaD
Nitrazepam—GABRG2—Neuronal System—HRAS—urinary bladder cancer	5.84e-06	0.000637	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	5.78e-06	0.00063	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—PRSS3—urinary bladder cancer	5.63e-06	0.000614	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	5.51e-06	0.0006	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—NAT2—urinary bladder cancer	5.41e-06	0.000589	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	5.33e-06	0.000581	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	5.32e-06	0.00058	CbGpPWpGaD
Nitrazepam—GABRA1—Neuronal System—HRAS—urinary bladder cancer	5.11e-06	0.000557	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	5.07e-06	0.000553	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	4.93e-06	0.000537	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	4.83e-06	0.000526	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—RRM2—urinary bladder cancer	4.67e-06	0.000509	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—NAT1—urinary bladder cancer	4.58e-06	0.000499	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	4.58e-06	0.000499	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—TYMP—urinary bladder cancer	4.5e-06	0.000491	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	4.42e-06	0.000482	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—ENO2—urinary bladder cancer	4.32e-06	0.000471	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—HPGDS—urinary bladder cancer	4.32e-06	0.000471	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	4.32e-06	0.000471	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—GSTT1—urinary bladder cancer	4.19e-06	0.000457	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	4.19e-06	0.000456	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	4.11e-06	0.000449	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	4.08e-06	0.000445	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—NAT2—urinary bladder cancer	4.07e-06	0.000444	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	3.77e-06	0.000411	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	3.63e-06	0.000396	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	3.56e-06	0.000388	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—RRM2—urinary bladder cancer	3.51e-06	0.000383	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—NQO1—urinary bladder cancer	3.48e-06	0.00038	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	3.47e-06	0.000378	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—ENO2—urinary bladder cancer	3.25e-06	0.000355	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—HPGDS—urinary bladder cancer	3.25e-06	0.000355	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—GSTT1—urinary bladder cancer	3.16e-06	0.000344	CbGpPWpGaD
Nitrazepam—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.96e-06	0.000322	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	2.91e-06	0.000317	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.77e-06	0.000302	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—TYMS—urinary bladder cancer	2.7e-06	0.000294	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	2.67e-06	0.000291	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	2.67e-06	0.000291	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—NQO1—urinary bladder cancer	2.62e-06	0.000286	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—GPX1—urinary bladder cancer	2.56e-06	0.000279	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	2.51e-06	0.000274	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—NAT2—urinary bladder cancer	2.51e-06	0.000273	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	2.36e-06	0.000257	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—GSTP1—urinary bladder cancer	2.19e-06	0.000239	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—RRM2—urinary bladder cancer	2.17e-06	0.000236	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—TYMS—urinary bladder cancer	2.03e-06	0.000222	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—NCOR1—urinary bladder cancer	2.01e-06	0.000219	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—GSTM1—urinary bladder cancer	2.01e-06	0.000219	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.01e-06	0.000219	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.01e-06	0.000219	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.94e-06	0.000212	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—GPX1—urinary bladder cancer	1.93e-06	0.00021	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—PPARG—urinary bladder cancer	1.91e-06	0.000209	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—ERCC2—urinary bladder cancer	1.89e-06	0.000206	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	1.84e-06	0.0002	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.78e-06	0.000194	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.62e-06	0.000176	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	1.51e-06	0.000164	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—PPARG—urinary bladder cancer	1.44e-06	0.000157	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—CREBBP—urinary bladder cancer	1.38e-06	0.000151	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.35e-06	0.000147	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—PTEN—urinary bladder cancer	1.31e-06	0.000143	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.25e-06	0.000137	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—EP300—urinary bladder cancer	1.25e-06	0.000136	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.24e-06	0.000135	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.24e-06	0.000135	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.19e-06	0.000129	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.16e-06	0.000127	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—PTGS2—urinary bladder cancer	1.13e-06	0.000124	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.09e-06	0.000119	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—PTEN—urinary bladder cancer	9.89e-07	0.000108	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—EP300—urinary bladder cancer	9.43e-07	0.000103	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—PPARG—urinary bladder cancer	8.88e-07	9.68e-05	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	8.53e-07	9.3e-05	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	6.98e-07	7.61e-05	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—PTEN—urinary bladder cancer	6.09e-07	6.64e-05	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—EP300—urinary bladder cancer	5.81e-07	6.33e-05	CbGpPWpGaD
